A process designed to optimise the launching of generic products

· In-house technology with our own pharmaceutical development and analytical laboratories, enabling control at all critical stages of the product development process.

· International Regulatory and Patent Evaluation Department, providing full support for successful product launching with minimal risk.

· Supply of finished goods: we find the most suitable cGMP - certified contract manufacturer depending on the individual product and pharmaceutical form.
This is essentially a question of finding the highest, most reliable quality at the most competitive price based on our economies of scale and constant cost improvements.

· Continuous update and improvement of our dossiers:

· API + Manufacturing: 2 x 2 strategy (2 API + 2 Manufacturers) to guarantee competitive prices.

A process designed to optimise the launching of generic products (Imagen)